Jiang, Xiangkang
Yang, Jingyuan
Lin, Yao
Liu, Fei
Tao, Jiawei
Zhang, Wenbin
Xu, Jiefeng
Zhang, Mao
Funding for this research was provided by:
the Natural Science Foundation of China (82072126)
the Zhejiang Provincial Key Research and Development Program of China (2021C03073, 2021C03036, 2023C03085)
the Key Program Cosponsored by Zhejiang Province and National Health Commission of China (WKJ-ZJ-2207)
Article History
Received: 16 August 2023
Accepted: 9 October 2023
First Online: 14 November 2023
Declarations
:
: The experiments conducted on animals were approved by the Institutional Ethics Committee of the Second Affiliated Hospital of Zhejiang University School of Medicine. The approved project is: Study on the treatment of acute compartment syndrome with extracellular vesicles secreted by embryonic stem cell-derived mesenchymal stem cells (approval number: No. 2022-110, Approved Date: 07/28/2022). Methods for each procedure were performed in accordance with the approved guidelines and regulations. The manuscript adheres to the ARRIVE guidelines (ExternalRef removed) for the reporting of animal experiments.
: Not applicable.
: The authors have declared that no competing interest exists.